Caricamento...
A60 IMPROVING PROCESS IN THE EDMONTON PEDIATRIC INFLAMMATORY BOWEL DISEASE CLINIC: AN INFLIXIMAB INFUSION QUALITY IMPROVEMENT PROJECT
BACKGROUND: There is a growing body of literature demonstrating that sustained clinical remission using infliximab is related to adequate trough serum drug levels and inversely to the development of antibodies against the drug. Antibody formation typically occurs when serum drug levels fall too low;...
Salvato in:
| Pubblicato in: | J Can Assoc Gastroenterol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507801/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.061 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|